Consun Pharmaceutical Group Limited
CPHGF
$1.08
$0.0747.34%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -0.48% | 29.22% | -0.86% | -7.92% | 0.31% |
| Total Depreciation and Amortization | -0.48% | -38.78% | -0.86% | 1.73% | 0.32% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -0.48% | 154.32% | 0.86% | -184.49% | 0.31% |
| Change in Net Operating Assets | -0.48% | -- | -- | -- | -0.32% |
| Cash from Operations | -0.48% | 112.70% | -0.86% | -37.64% | 0.31% |
| Capital Expenditure | 0.48% | -33.84% | 0.86% | -31.85% | -0.32% |
| Sale of Property, Plant, and Equipment | 0.00% | -131.61% | -0.90% | 6,540.00% | 0.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -0.48% | 131.23% | 0.86% | 58.09% | -0.31% |
| Cash from Investing | 0.48% | 82.71% | 0.86% | 47.77% | -0.31% |
| Total Debt Issued | 0.00% | 25.95% | 0.00% | 45.92% | 0.00% |
| Total Debt Repaid | 0.00% | -146.52% | 0.00% | -33.82% | 0.00% |
| Issuance of Common Stock | 0.00% | -84.75% | 0.00% | 2,352.02% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.48% | 48.25% | 0.86% | -283.11% | -0.31% |
| Other Financing Activities | 0.00% | 604.30% | 0.00% | -1.28% | 0.00% |
| Cash from Financing | 0.48% | -14.68% | 0.86% | -141.12% | -0.31% |
| Foreign Exchange rate Adjustments | 0.48% | -707.65% | 0.90% | 88.38% | -0.32% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -0.48% | 307.01% | 0.86% | -247.23% | 0.31% |